Skip to main content
. 2022 Dec 7;50(4):1158–1167. doi: 10.1007/s00259-022-06070-7

Fig. 1.

Fig. 1

Example of maximum intensity projection (MIP) [18F]FDG PET images of a 74-year-old man with stage IV cutaneous melanoma planned for treatment with immune checkpoint inhibitors. Presented are the PET-10, PET-8, PET-6, PET-5, PET-4, and PET-2 acquisitions. All acquisitions clearly demonstrate disseminated [18F]FDG-avid metastastic disease